Reportlinker has released the latest research report titled “Nanotechnology for Drug Delivery: Global Market for Nanocarriers”. According to the report, by 2021, 40% of the drug delivery market will be captured by nanocarriers. The overall market size is expected to reach $136 billion in 2021 with nanocarriers and nanocrystals being the major players.
Among the 10 nanocarrier technologies, gold nanocarriers and liposomes lead the market share by 45%. In the next 10 years, gold nanoparticles, which act as carriers, are foreseen to have better compound annual growth rate, while liposomes are expected to provide a bigger market in 2021.
Usually, a mechanism is used for treating cancer. The targeted drug delivery systems accurately deliver the drug to the target site of the body when compared to other techniques. Normally, patients are bombarded with drugs for killing the tumor cells which result in wastage of 90% of drug. Moreover, the drug may kill the normal cells, which lead to numerous side effects.
Numerous researches have been done on nanoparticles and drug delivery mechanism. As more researchers discover the cause of a particular disease at a molecular level, there are more possibilities of developing new nanotechnology based drug therapy.
The research report consists of four chapters. The first chapter introduces the scope and the method followed for the research; the second chapter deals about the application of nanotechnology in biomedicine and medicine; the third chapter speaks about the risk involved and regulation implied on nanotechnology; and the fourth chapter discusses about the worldwide market for nanocarriers.
Source: http://www.reportlinker.com